Third Level Education for PWCF

CFI developed a booklet to make the process of transition to third level as straight forward as possible for a person with Cystic Fibrosis, and to help answer some of the many questions that may arise at that time. Click here to view this document.

Disability Access Route to Education

The Disability Access Route to Education (DARE) is a college and university admissions scheme which offers places on reduced points to school leavers with disabilities. DARE has been set up by a number of colleges and universities as evidence shows that disability can have a negative impact on how well a student does at school and whether they go on to college.

What does "reduced points" mean?Students who are eligible for DARE may get a place in college with less than the full CAO points. For example, a course which needs 450 Leaving Certificate points through the CAO may be offered to a DARE student with 410 points. However, DARE students must still meet the enrolment (matriculation) and specific course entry requirements where they apply.

Which colleges take part in DARE?

Athlone Institute of Technology

Cork Institute of Technology

Dublin City University

Dublin Institute of Technology

Mater Dei Institute

National College of Ireland

NUI Galway

Maynooth University

Pontifical University, Maynooth

Trinity College, Dublin

University College Dublin

University College Cork

University of Limerick

Students can apply through DARE for the 'reduced points' places in any of these colleges.

Watch the following video to help you through the application process for the DARE scheme this year.

Contacts

About us

CF Ireland (CFI) is a voluntary organisation that was set up by parents in 1963 to improve the treatment and facilities for people with Cystic Fibrosis in Ireland. CF Ireland also co-operates with medical professionals to give maximum assistance to both parents and children/adults with Cystic Fibrosis.

We are supported by fundraising and voluntary contributions and are solely concerned with the well-being of people with Cystic Fibrosis.